Logo image of CRWD

CROWDSTRIKE HOLDINGS INC - A (CRWD) Stock Fundamental Analysis

NASDAQ:CRWD - Nasdaq - US22788C1053 - Common Stock - Currency: USD

437.51  -4.74 (-1.07%)

Fundamental Rating

5

Taking everything into account, CRWD scores 5 out of 10 in our fundamental rating. CRWD was compared to 283 industry peers in the Software industry. While CRWD seems to be doing ok healthwise, there are quite some concerns on its profitability. CRWD is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year CRWD was profitable.
CRWD had a positive operating cash flow in the past year.
CRWD had negative earnings in 4 of the past 5 years.
CRWD had a positive operating cash flow in each of the past 5 years.
CRWD Yearly Net Income VS EBIT VS OCF VS FCFCRWD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B

1.2 Ratios

The Return On Assets of CRWD (-0.22%) is better than 63.96% of its industry peers.
CRWD has a better Return On Equity (-0.59%) than 65.02% of its industry peers.
Industry RankSector Rank
ROA -0.22%
ROE -0.59%
ROIC N/A
ROA(3y)-0.84%
ROA(5y)-2.48%
ROE(3y)-3.08%
ROE(5y)-8.55%
ROIC(3y)N/A
ROIC(5y)N/A
CRWD Yearly ROA, ROE, ROICCRWD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -1K -2K -3K

1.3 Margins

CRWD has a better Gross Margin (74.92%) than 67.49% of its industry peers.
In the last couple of years the Gross Margin of CRWD has remained more or less at the same level.
CRWD does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 74.92%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.59%
GM growth 5Y1.2%
CRWD Yearly Profit, Operating, Gross MarginsCRWD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100 -150 -200

6

2. Health

2.1 Basic Checks

CRWD does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CRWD has more shares outstanding
Compared to 5 years ago, CRWD has more shares outstanding
Compared to 1 year ago, CRWD has an improved debt to assets ratio.
CRWD Yearly Shares OutstandingCRWD Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
CRWD Yearly Total Debt VS Total AssetsCRWD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

CRWD has an Altman-Z score of 12.73. This indicates that CRWD is financially healthy and has little risk of bankruptcy at the moment.
CRWD has a better Altman-Z score (12.73) than 88.69% of its industry peers.
The Debt to FCF ratio of CRWD is 0.70, which is an excellent value as it means it would take CRWD, only 0.70 years of fcf income to pay off all of its debts.
CRWD's Debt to FCF ratio of 0.70 is fine compared to the rest of the industry. CRWD outperforms 74.56% of its industry peers.
CRWD has a Debt/Equity ratio of 0.23. This is a healthy value indicating a solid balance between debt and equity.
CRWD has a Debt to Equity ratio of 0.23. This is comparable to the rest of the industry: CRWD outperforms 44.88% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF 0.7
Altman-Z 12.73
ROIC/WACCN/A
WACC10.91%
CRWD Yearly LT Debt VS Equity VS FCFCRWD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B

2.3 Liquidity

CRWD has a Current Ratio of 1.77. This is a normal value and indicates that CRWD is financially healthy and should not expect problems in meeting its short term obligations.
CRWD has a Current ratio (1.77) which is in line with its industry peers.
CRWD has a Quick Ratio of 1.77. This is a normal value and indicates that CRWD is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.77, CRWD is in line with its industry, outperforming 55.12% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.77
Quick Ratio 1.77
CRWD Yearly Current Assets VS Current LiabilitesCRWD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

9

3. Growth

3.1 Past

CRWD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 27.60%, which is quite impressive.
CRWD shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 79.46% yearly.
The Revenue has grown by 29.39% in the past year. This is a very strong growth!
The Revenue has been growing by 52.37% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)27.6%
EPS 3Y79.46%
EPS 5YN/A
EPS Q2Q%8.42%
Revenue 1Y (TTM)29.39%
Revenue growth 3Y39.65%
Revenue growth 5Y52.37%
Sales Q2Q%25.22%

3.2 Future

The Earnings Per Share is expected to grow by 17.93% on average over the next years. This is quite good.
The Revenue is expected to grow by 22.02% on average over the next years. This is a very strong growth
EPS Next Y-10.92%
EPS Next 2Y9.12%
EPS Next 3Y17.22%
EPS Next 5Y17.93%
Revenue Next Year21.51%
Revenue Next 2Y21.47%
Revenue Next 3Y21.61%
Revenue Next 5Y22.02%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
CRWD Yearly Revenue VS EstimatesCRWD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 5B 10B 15B
CRWD Yearly EPS VS EstimatesCRWD Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 5 10 15 20

1

4. Valuation

4.1 Price/Earnings Ratio

CRWD is valuated quite expensively with a Price/Earnings ratio of 111.33.
CRWD's Price/Earnings ratio is in line with the industry average.
When comparing the Price/Earnings ratio of CRWD to the average of the S&P500 Index (26.60), we can say CRWD is valued expensively.
A Price/Forward Earnings ratio of 124.98 indicates a quite expensive valuation of CRWD.
Based on the Price/Forward Earnings ratio, CRWD is valued a bit more expensive than the industry average as 61.13% of the companies are valued more cheaply.
CRWD is valuated expensively when we compare the Price/Forward Earnings ratio to 22.43, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 111.33
Fwd PE 124.98
CRWD Price Earnings VS Forward Price EarningsCRWD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

CRWD's Enterprise Value to EBITDA ratio is in line with the industry average.
CRWD's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 101.55
EV/EBITDA 1102
CRWD Per share dataCRWD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

A more expensive valuation may be justified as CRWD's earnings are expected to grow with 17.22% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y9.12%
EPS Next 3Y17.22%

0

5. Dividend

5.1 Amount

CRWD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CROWDSTRIKE HOLDINGS INC - A

NASDAQ:CRWD (5/21/2025, 10:00:03 AM)

437.51

-4.74 (-1.07%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)03-04 2025-03-04/amc
Earnings (Next)06-03 2025-06-03/amc
Inst Owners72.36%
Inst Owner Change3.16%
Ins Owners1.5%
Ins Owner Change38.17%
Market Cap108.45B
Analysts81.38
Price Target412.77 (-5.65%)
Short Float %3.71%
Short Ratio1.98
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)15.79%
Min EPS beat(2)12.96%
Max EPS beat(2)18.62%
EPS beat(4)4
Avg EPS beat(4)9.65%
Min EPS beat(4)1.99%
Max EPS beat(4)18.62%
EPS beat(8)8
Avg EPS beat(8)12.6%
EPS beat(12)12
Avg EPS beat(12)16.15%
EPS beat(16)16
Avg EPS beat(16)25.73%
Revenue beat(2)2
Avg Revenue beat(2)0.67%
Min Revenue beat(2)0.53%
Max Revenue beat(2)0.82%
Revenue beat(4)2
Avg Revenue beat(4)-0.07%
Min Revenue beat(4)-1.42%
Max Revenue beat(4)0.82%
Revenue beat(8)3
Avg Revenue beat(8)-0.36%
Revenue beat(12)5
Avg Revenue beat(12)0.12%
Revenue beat(16)9
Avg Revenue beat(16)0.69%
PT rev (1m)0.61%
PT rev (3m)5.03%
EPS NQ rev (1m)0.02%
EPS NQ rev (3m)-31.08%
EPS NY rev (1m)0.01%
EPS NY rev (3m)-21.85%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.18%
Revenue NY rev (1m)-0.18%
Revenue NY rev (3m)0.23%
Valuation
Industry RankSector Rank
PE 111.33
Fwd PE 124.98
P/S 27.43
P/FCF 101.55
P/OCF 78.49
P/B 33.07
P/tB 48.55
EV/EBITDA 1102
EPS(TTM)3.93
EY0.9%
EPS(NY)3.5
Fwd EY0.8%
FCF(TTM)4.31
FCFY0.98%
OCF(TTM)5.57
OCFY1.27%
SpS15.95
BVpS13.23
TBVpS9.01
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.22%
ROE -0.59%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 74.92%
FCFM 27.01%
ROA(3y)-0.84%
ROA(5y)-2.48%
ROE(3y)-3.08%
ROE(5y)-8.55%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.59%
GM growth 5Y1.2%
F-Score4
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF 0.7
Debt/EBITDA 7.73
Cap/Depr 146.68%
Cap/Sales 7.94%
Interest Coverage N/A
Cash Conversion 1435.92%
Profit Quality N/A
Current Ratio 1.77
Quick Ratio 1.77
Altman-Z 12.73
F-Score4
WACC10.91%
ROIC/WACCN/A
Cap/Depr(3y)197.98%
Cap/Depr(5y)189.47%
Cap/Sales(3y)9.19%
Cap/Sales(5y)8.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)27.6%
EPS 3Y79.46%
EPS 5YN/A
EPS Q2Q%8.42%
EPS Next Y-10.92%
EPS Next 2Y9.12%
EPS Next 3Y17.22%
EPS Next 5Y17.93%
Revenue 1Y (TTM)29.39%
Revenue growth 3Y39.65%
Revenue growth 5Y52.37%
Sales Q2Q%25.22%
Revenue Next Year21.51%
Revenue Next 2Y21.47%
Revenue Next 3Y21.61%
Revenue Next 5Y22.02%
EBIT growth 1Y-19489%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year44.3%
EBIT Next 3Y36.43%
EBIT Next 5YN/A
FCF growth 1Y14.94%
FCF growth 3Y34.28%
FCF growth 5Y143.79%
OCF growth 1Y18.48%
OCF growth 3Y33.96%
OCF growth 5Y69.11%